

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.89431845 |
| 2 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.61300353 |
| 3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.35484658 |
| 4 | DNA unwinding involved in DNA replication (GO:0006268) | 4.32055484 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.20983998 |
| 6 | IMP biosynthetic process (GO:0006188) | 4.12327852 |
| 7 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.12311933 |
| 8 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.10644469 |
| 9 | regulation of mitochondrial translation (GO:0070129) | 4.09880136 |
| 10 | DNA replication initiation (GO:0006270) | 3.97946158 |
| 11 | folic acid metabolic process (GO:0046655) | 3.95174203 |
| 12 | DNA strand elongation (GO:0022616) | 3.91911676 |
| 13 | heme biosynthetic process (GO:0006783) | 3.91036215 |
| 14 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.90510709 |
| 15 | nucleobase biosynthetic process (GO:0046112) | 3.89566132 |
| 16 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.87846563 |
| 17 | establishment of integrated proviral latency (GO:0075713) | 3.85368524 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 3.81783893 |
| 19 | protein localization to kinetochore (GO:0034501) | 3.79296371 |
| 20 | glycine metabolic process (GO:0006544) | 3.79169476 |
| 21 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.77449644 |
| 22 | ribosomal small subunit assembly (GO:0000028) | 3.71674712 |
| 23 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.70734426 |
| 24 | IMP metabolic process (GO:0046040) | 3.68742551 |
| 25 | DNA deamination (GO:0045006) | 3.61819192 |
| 26 | tetrahydrofolate metabolic process (GO:0046653) | 3.55078292 |
| 27 | GDP-mannose metabolic process (GO:0019673) | 3.54249322 |
| 28 | maturation of SSU-rRNA (GO:0030490) | 3.48108952 |
| 29 | serine family amino acid biosynthetic process (GO:0009070) | 3.45382736 |
| 30 | proteasome assembly (GO:0043248) | 3.44385674 |
| 31 | viral transcription (GO:0019083) | 3.44352524 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 3.44093144 |
| 33 | mitotic nuclear envelope disassembly (GO:0007077) | 3.41176905 |
| 34 | rRNA modification (GO:0000154) | 3.40171403 |
| 35 | translational termination (GO:0006415) | 3.38222701 |
| 36 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.37768830 |
| 37 | establishment of viral latency (GO:0019043) | 3.33524101 |
| 38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.31645073 |
| 39 | Golgi transport vesicle coating (GO:0048200) | 3.29369547 |
| 40 | COPI coating of Golgi vesicle (GO:0048205) | 3.29369547 |
| 41 | mitotic nuclear envelope reassembly (GO:0007084) | 3.26466394 |
| 42 | nuclear envelope reassembly (GO:0031468) | 3.26466394 |
| 43 | histone arginine methylation (GO:0034969) | 3.25352695 |
| 44 | lysine metabolic process (GO:0006553) | 3.25334363 |
| 45 | lysine catabolic process (GO:0006554) | 3.25334363 |
| 46 | tetrapyrrole biosynthetic process (GO:0033014) | 3.25036973 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.24651365 |
| 48 | translational elongation (GO:0006414) | 3.23855997 |
| 49 | DNA replication checkpoint (GO:0000076) | 3.23123978 |
| 50 | heme metabolic process (GO:0042168) | 3.22982853 |
| 51 | protein localization to chromosome, centromeric region (GO:0071459) | 3.22793011 |
| 52 | folic acid-containing compound metabolic process (GO:0006760) | 3.21048260 |
| 53 | regulation of translational fidelity (GO:0006450) | 3.19330110 |
| 54 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.19240161 |
| 55 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.19240161 |
| 56 | protein targeting to mitochondrion (GO:0006626) | 3.17594752 |
| 57 | tRNA methylation (GO:0030488) | 3.16851153 |
| 58 | telomere maintenance via recombination (GO:0000722) | 3.16100639 |
| 59 | transcription from mitochondrial promoter (GO:0006390) | 3.15851499 |
| 60 | viral mRNA export from host cell nucleus (GO:0046784) | 3.15159258 |
| 61 | L-serine metabolic process (GO:0006563) | 3.14778663 |
| 62 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.13268548 |
| 63 | ribosome biogenesis (GO:0042254) | 3.12522456 |
| 64 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.10423471 |
| 65 | porphyrin-containing compound metabolic process (GO:0006778) | 3.10400571 |
| 66 | membrane disassembly (GO:0030397) | 3.10302683 |
| 67 | nuclear envelope disassembly (GO:0051081) | 3.10302683 |
| 68 | translational initiation (GO:0006413) | 3.08305675 |
| 69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.06240502 |
| 70 | negative regulation of ligase activity (GO:0051352) | 3.06240502 |
| 71 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.05213363 |
| 72 | rRNA transcription (GO:0009303) | 3.04750681 |
| 73 | peptidyl-arginine N-methylation (GO:0035246) | 3.04620798 |
| 74 | peptidyl-arginine methylation (GO:0018216) | 3.04620798 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.04208248 |
| 76 | one-carbon metabolic process (GO:0006730) | 3.03671988 |
| 77 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.01818622 |
| 78 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.01787884 |
| 79 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.98177534 |
| 80 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.97852645 |
| 81 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.97199875 |
| 82 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.95996413 |
| 83 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.95891653 |
| 84 | nuclear pore organization (GO:0006999) | 2.94079264 |
| 85 | mitochondrial fusion (GO:0008053) | 2.93624623 |
| 86 | mitotic recombination (GO:0006312) | 2.93237632 |
| 87 | NADH metabolic process (GO:0006734) | 2.92009008 |
| 88 | ribosomal small subunit biogenesis (GO:0042274) | 2.91836829 |
| 89 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.91388752 |
| 90 | cellular component biogenesis (GO:0044085) | 2.88788148 |
| 91 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.87429053 |
| 92 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.87377101 |
| 93 | telomere maintenance via telomere lengthening (GO:0010833) | 2.87070313 |
| 94 | regulation of translational termination (GO:0006449) | 2.85854353 |
| 95 | establishment of protein localization to mitochondrion (GO:0072655) | 2.85778208 |
| 96 | ribosomal large subunit biogenesis (GO:0042273) | 2.85604312 |
| 97 | base-excision repair (GO:0006284) | 2.85520660 |
| 98 | DNA duplex unwinding (GO:0032508) | 2.84828963 |
| 99 | DNA geometric change (GO:0032392) | 2.83718636 |
| 100 | spliceosomal snRNP assembly (GO:0000387) | 2.83154885 |
| 101 | cysteine metabolic process (GO:0006534) | 2.82417226 |
| 102 | pentose-phosphate shunt (GO:0006098) | 2.82353288 |
| 103 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.82154109 |
| 104 | glucose catabolic process (GO:0006007) | 2.81051328 |
| 105 | pteridine-containing compound metabolic process (GO:0042558) | 2.80763193 |
| 106 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.80054332 |
| 107 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.79237242 |
| 108 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.78544007 |
| 109 | oxidative phosphorylation (GO:0006119) | 2.76205728 |
| 110 | mitotic sister chromatid segregation (GO:0000070) | 2.76116385 |
| 111 | ribosome assembly (GO:0042255) | 2.75745979 |
| 112 | protein complex localization (GO:0031503) | 2.73992163 |
| 113 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.73858764 |
| 114 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.73800801 |
| 115 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.73800801 |
| 116 | protein localization to mitochondrion (GO:0070585) | 2.73565233 |
| 117 | pseudouridine synthesis (GO:0001522) | 2.72530557 |
| 118 | valine metabolic process (GO:0006573) | 2.72337072 |
| 119 | peptidyl-histidine modification (GO:0018202) | 2.71073765 |
| 120 | mitotic chromosome condensation (GO:0007076) | 2.70679080 |
| 121 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.70415434 |
| 122 | protein targeting to ER (GO:0045047) | 2.69809712 |
| 123 | proline biosynthetic process (GO:0006561) | 2.69686330 |
| 124 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.69326419 |
| 125 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.69326419 |
| 126 | chaperone-mediated protein transport (GO:0072321) | 2.69194383 |
| 127 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.68970560 |
| 128 | UV protection (GO:0009650) | 2.68591264 |
| 129 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.68257027 |
| 130 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.68257027 |
| 131 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.67831437 |
| 132 | cotranslational protein targeting to membrane (GO:0006613) | 2.67691648 |
| 133 | nucleotide salvage (GO:0043173) | 2.66872803 |
| 134 | proline metabolic process (GO:0006560) | 2.66777203 |
| 135 | rRNA processing (GO:0006364) | 2.66353504 |
| 136 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.65477716 |
| 137 | mitotic metaphase plate congression (GO:0007080) | 2.65172244 |
| 138 | nuclear pore complex assembly (GO:0051292) | 2.64111033 |
| 139 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.62768530 |
| 140 | UMP metabolic process (GO:0046049) | 2.62768530 |
| 141 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.62768530 |
| 142 | UMP biosynthetic process (GO:0006222) | 2.62768530 |
| 143 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.62149747 |
| 144 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.59946276 |
| 145 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57974855 |
| 146 | rRNA metabolic process (GO:0016072) | 2.57600784 |
| 147 | cellular protein complex disassembly (GO:0043624) | 2.56728656 |
| 148 | mitochondrial DNA metabolic process (GO:0032042) | 2.56272294 |
| 149 | viral life cycle (GO:0019058) | 2.55774849 |
| 150 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.55741140 |
| 151 | erythrocyte maturation (GO:0043249) | 2.55141811 |
| 152 | mitochondrial RNA metabolic process (GO:0000959) | 2.52063283 |
| 153 | protein localization to endoplasmic reticulum (GO:0070972) | 2.51659518 |
| 154 | serine family amino acid catabolic process (GO:0009071) | 2.50811686 |
| 155 | tRNA aminoacylation for protein translation (GO:0006418) | 2.49914658 |
| 156 | maternal placenta development (GO:0001893) | 2.48275044 |
| 157 | sister chromatid segregation (GO:0000819) | 2.48040609 |
| 158 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.46785181 |
| 159 | NADPH regeneration (GO:0006740) | 2.45415538 |
| 160 | pigment biosynthetic process (GO:0046148) | 2.43053411 |
| 161 | nucleoside salvage (GO:0043174) | 2.42374774 |
| 162 | tRNA aminoacylation (GO:0043039) | 2.42208902 |
| 163 | amino acid activation (GO:0043038) | 2.42208902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.02715586 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.32193527 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.69091815 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.19813882 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.81126741 |
| 6 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.63890080 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.50654378 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.49171566 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47693458 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43634980 |
| 11 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.38610449 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.18570344 |
| 13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.18483900 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.15480694 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.15395334 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.13939869 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03359589 |
| 18 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.00384368 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95414046 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94013045 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86857926 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.81991397 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73495694 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73387814 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.73131060 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70210539 |
| 27 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.68979133 |
| 28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64689802 |
| 29 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.64054811 |
| 30 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.63727109 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62983033 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59475512 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58760977 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.57455179 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57165761 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56377646 |
| 37 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53261390 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53163109 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52823576 |
| 40 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52796839 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.51294878 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50438600 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50024570 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48897401 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48550990 |
| 46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.46508977 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45454984 |
| 48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41222365 |
| 49 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.41104597 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40223638 |
| 51 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38274594 |
| 52 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38211968 |
| 53 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37733047 |
| 54 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.35334208 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34791165 |
| 56 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34647024 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34101555 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29878608 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28279294 |
| 60 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.27959248 |
| 61 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26794478 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24997758 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24956720 |
| 64 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23391721 |
| 65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22872640 |
| 66 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18733130 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18399955 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17709448 |
| 69 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17160157 |
| 70 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16664663 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16467241 |
| 72 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16462556 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16348095 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15803339 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15005447 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13907406 |
| 77 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13076882 |
| 78 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12197763 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12134824 |
| 80 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11366913 |
| 81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10152573 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10112459 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08059974 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06673629 |
| 85 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.06655632 |
| 86 | * P68_20966046_ChIP-Seq_HELA_Human | 1.06502916 |
| 87 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06187435 |
| 88 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.05927264 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05103394 |
| 90 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04765839 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04055331 |
| 92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04009025 |
| 93 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03649280 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03502115 |
| 95 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.02835811 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02748556 |
| 97 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02223176 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02068619 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00829872 |
| 100 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00706088 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00568677 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00532033 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00473152 |
| 104 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99601328 |
| 105 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97823787 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97597122 |
| 107 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97267435 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95909516 |
| 109 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95671927 |
| 110 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93821693 |
| 111 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.91980311 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91711251 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90870087 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90723571 |
| 115 | MAF_26560356_Chip-Seq_TH1_Human | 0.90596124 |
| 116 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89558384 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87475608 |
| 118 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87285624 |
| 119 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86746547 |
| 120 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.86410044 |
| 121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85952139 |
| 122 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85654147 |
| 123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.85624854 |
| 124 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.85523565 |
| 125 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.83349683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.78710221 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.74540761 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.49367300 |
| 4 | MP0005451_abnormal_body_composition | 3.41219533 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.20468385 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.03240134 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.99779677 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.94364268 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.92228108 |
| 10 | MP0005360_urolithiasis | 2.86455141 |
| 11 | MP0004147_increased_porphyrin_level | 2.70701595 |
| 12 | MP0003077_abnormal_cell_cycle | 2.63466000 |
| 13 | MP0008057_abnormal_DNA_replication | 2.47640582 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.41548319 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.25301859 |
| 16 | MP0005365_abnormal_bile_salt | 2.21791356 |
| 17 | MP0004233_abnormal_muscle_weight | 2.11396364 |
| 18 | MP0005083_abnormal_biliary_tract | 2.11290500 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.01386143 |
| 20 | MP0009840_abnormal_foam_cell | 1.88295828 |
| 21 | MP0008260_abnormal_autophagy | 1.84569672 |
| 22 | MP0001661_extended_life_span | 1.84023297 |
| 23 | MP0001730_embryonic_growth_arrest | 1.79039340 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.78852274 |
| 25 | MP0000751_myopathy | 1.77983927 |
| 26 | MP0008058_abnormal_DNA_repair | 1.75695649 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.73561041 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.58628509 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.55239407 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.55239407 |
| 31 | MP0000490_abnormal_crypts_of | 1.54478087 |
| 32 | MP0000350_abnormal_cell_proliferation | 1.53854352 |
| 33 | MP0003186_abnormal_redox_activity | 1.52113867 |
| 34 | MP0002796_impaired_skin_barrier | 1.51982583 |
| 35 | MP0009697_abnormal_copulation | 1.48493069 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.46251921 |
| 37 | MP0010307_abnormal_tumor_latency | 1.43189059 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37522771 |
| 39 | MP0006054_spinal_hemorrhage | 1.34776682 |
| 40 | MP0010030_abnormal_orbit_morphology | 1.34323271 |
| 41 | MP0005380_embryogenesis_phenotype | 1.32170247 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.32170247 |
| 43 | MP0008932_abnormal_embryonic_tissue | 1.31277423 |
| 44 | MP0000609_abnormal_liver_physiology | 1.31268677 |
| 45 | MP0003984_embryonic_growth_retardation | 1.29999366 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.27694080 |
| 47 | MP0002080_prenatal_lethality | 1.27657670 |
| 48 | MP0002088_abnormal_embryonic_growth/wei | 1.27550713 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.27535294 |
| 50 | MP0002060_abnormal_skin_morphology | 1.27213468 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.26755087 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.25019325 |
| 53 | MP0005332_abnormal_amino_acid | 1.24544482 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.24441289 |
| 55 | MP0003315_abnormal_perineum_morphology | 1.22009356 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.21506269 |
| 57 | MP0001697_abnormal_embryo_size | 1.21377776 |
| 58 | MP0005165_increased_susceptibility_to | 1.21239925 |
| 59 | MP0001849_ear_inflammation | 1.21000384 |
| 60 | MP0000537_abnormal_urethra_morphology | 1.20280188 |
| 61 | MP0002086_abnormal_extraembryonic_tissu | 1.17143697 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.16314011 |
| 63 | MP0000747_muscle_weakness | 1.15974461 |
| 64 | MP0010329_abnormal_lipoprotein_level | 1.15950107 |
| 65 | MP0000313_abnormal_cell_death | 1.14395973 |
| 66 | MP0000598_abnormal_liver_morphology | 1.14226531 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.12659346 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.11836240 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 1.11782868 |
| 70 | MP0000759_abnormal_skeletal_muscle | 1.11606892 |
| 71 | MP0003252_abnormal_bile_duct | 1.11456396 |
| 72 | MP0003567_abnormal_fetal_cardiomyocyte | 1.11380597 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 1.09561667 |
| 74 | MP0004197_abnormal_fetal_growth/weight/ | 1.06282676 |
| 75 | MP0002269_muscular_atrophy | 1.05800748 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.03811184 |
| 77 | MP0002722_abnormal_immune_system | 1.03420641 |
| 78 | MP0001764_abnormal_homeostasis | 1.02190061 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01042815 |
| 80 | MP0000858_altered_metastatic_potential | 1.00957245 |
| 81 | MP0005266_abnormal_metabolism | 1.00866374 |
| 82 | MP0005330_cardiomyopathy | 0.99113264 |
| 83 | MP0003786_premature_aging | 0.97891526 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.97045625 |
| 85 | MP0000358_abnormal_cell_content/ | 0.96695051 |
| 86 | MP0002398_abnormal_bone_marrow | 0.96101290 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.95948506 |
| 88 | MP0004858_abnormal_nervous_system | 0.95615132 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.93305475 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.93011423 |
| 91 | MP0003646_muscle_fatigue | 0.92802200 |
| 92 | MP0001881_abnormal_mammary_gland | 0.92745405 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.92101533 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.92008362 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.91977739 |
| 96 | MP0004084_abnormal_cardiac_muscle | 0.91528000 |
| 97 | MP0002132_abnormal_respiratory_system | 0.91524845 |
| 98 | MP0003123_paternal_imprinting | 0.91446650 |
| 99 | MP0005621_abnormal_cell_physiology | 0.88813741 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.88694366 |
| 101 | MP0002085_abnormal_embryonic_tissue | 0.87987091 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.87638730 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.87283280 |
| 104 | MP0001243_abnormal_dermal_layer | 0.86692208 |
| 105 | MP0005384_cellular_phenotype | 0.84273837 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.83748829 |
| 107 | MP0009672_abnormal_birth_weight | 0.82459600 |
| 108 | MP0002429_abnormal_blood_cell | 0.82239903 |
| 109 | MP0003950_abnormal_plasma_membrane | 0.81482180 |
| 110 | MP0001853_heart_inflammation | 0.81165610 |
| 111 | MP0009053_abnormal_anal_canal | 0.80476103 |
| 112 | MP0005257_abnormal_intraocular_pressure | 0.80447903 |
| 113 | MP0005501_abnormal_skin_physiology | 0.79612070 |
| 114 | MP0003718_maternal_effect | 0.78495670 |
| 115 | MP0002084_abnormal_developmental_patter | 0.78241955 |
| 116 | MP0001873_stomach_inflammation | 0.78006345 |
| 117 | MP0010630_abnormal_cardiac_muscle | 0.77887536 |
| 118 | MP0005023_abnormal_wound_healing | 0.77711126 |
| 119 | MP0000749_muscle_degeneration | 0.77261652 |
| 120 | MP0000733_abnormal_muscle_development | 0.76264291 |
| 121 | MP0001727_abnormal_embryo_implantation | 0.76044682 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.75709140 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.74781496 |
| 124 | MP0000685_abnormal_immune_system | 0.73776165 |
| 125 | MP0010771_integument_phenotype | 0.72489230 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.72125849 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.71995700 |
| 128 | MP0000762_abnormal_tongue_morphology | 0.70673128 |
| 129 | MP0001915_intracranial_hemorrhage | 0.70518468 |
| 130 | MP0005464_abnormal_platelet_physiology | 0.70387095 |
| 131 | MP0002970_abnormal_white_adipose | 0.69990783 |
| 132 | MP0004272_abnormal_basement_membrane | 0.69552694 |
| 133 | MP0009278_abnormal_bone_marrow | 0.69300395 |
| 134 | MP0005670_abnormal_white_adipose | 0.68489198 |
| 135 | MP0004185_abnormal_adipocyte_glucose | 0.67803854 |
| 136 | MP0004087_abnormal_muscle_fiber | 0.67758250 |
| 137 | MP0009931_abnormal_skin_appearance | 0.67225036 |
| 138 | MP0009763_increased_sensitivity_to | 0.65984163 |
| 139 | MP0002138_abnormal_hepatobiliary_system | 0.64840420 |
| 140 | MP0000477_abnormal_intestine_morphology | 0.64686990 |
| 141 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63374465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.45017634 |
| 2 | Poikilocytosis (HP:0004447) | 4.49352836 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.18040206 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.12953690 |
| 5 | Reticulocytosis (HP:0001923) | 4.05702681 |
| 6 | Microvesicular hepatic steatosis (HP:0001414) | 3.80962858 |
| 7 | Abnormality of reticulocytes (HP:0004312) | 3.66912216 |
| 8 | Acanthocytosis (HP:0001927) | 3.36582559 |
| 9 | Multiple enchondromatosis (HP:0005701) | 3.34545008 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.22833152 |
| 11 | Hyperbilirubinemia (HP:0002904) | 3.20859308 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.19361511 |
| 13 | Testicular atrophy (HP:0000029) | 3.18039178 |
| 14 | Abnormality of glycolysis (HP:0004366) | 3.04745410 |
| 15 | Oral leukoplakia (HP:0002745) | 2.99751993 |
| 16 | Reticulocytopenia (HP:0001896) | 2.97951388 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 2.97006435 |
| 18 | Birth length less than 3rd percentile (HP:0003561) | 2.96161030 |
| 19 | Cholelithiasis (HP:0001081) | 2.94915230 |
| 20 | Hyperammonemia (HP:0001987) | 2.88121772 |
| 21 | Increased serum pyruvate (HP:0003542) | 2.87321042 |
| 22 | Hypochromic microcytic anemia (HP:0004840) | 2.84021624 |
| 23 | Hepatocellular necrosis (HP:0001404) | 2.81306994 |
| 24 | Myopathic facies (HP:0002058) | 2.79427553 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 2.78142582 |
| 26 | Achilles tendon contracture (HP:0001771) | 2.77421593 |
| 27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.76558124 |
| 28 | Increased serum ferritin (HP:0003281) | 2.75404785 |
| 29 | Rhabdomyolysis (HP:0003201) | 2.74478145 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 2.73166570 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.72994331 |
| 32 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.70571529 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 2.68076697 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.63263261 |
| 35 | Increased muscle lipid content (HP:0009058) | 2.62957068 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.61697152 |
| 37 | Abnormality of iron homeostasis (HP:0011031) | 2.61277269 |
| 38 | Abnormality of the umbilical cord (HP:0010881) | 2.60698600 |
| 39 | Abnormal gallbladder morphology (HP:0012437) | 2.56665774 |
| 40 | Hyperglycinuria (HP:0003108) | 2.55545349 |
| 41 | Ependymoma (HP:0002888) | 2.54351866 |
| 42 | Macrocytic anemia (HP:0001972) | 2.52394523 |
| 43 | Exercise intolerance (HP:0003546) | 2.50034372 |
| 44 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.48749729 |
| 45 | Exercise-induced myalgia (HP:0003738) | 2.48422990 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 2.47132513 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 2.46796013 |
| 48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46706428 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.46637393 |
| 50 | Nausea (HP:0002018) | 2.45751391 |
| 51 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.41130550 |
| 52 | Hypochromic anemia (HP:0001931) | 2.41042563 |
| 53 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.40627178 |
| 54 | Aplastic anemia (HP:0001915) | 2.39300385 |
| 55 | Progressive muscle weakness (HP:0003323) | 2.37227313 |
| 56 | Abnormal trabecular bone morphology (HP:0100671) | 2.34979055 |
| 57 | Pallor (HP:0000980) | 2.34671175 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.33953954 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.33953954 |
| 60 | Selective tooth agenesis (HP:0001592) | 2.33602101 |
| 61 | Diaphragmatic weakness (HP:0009113) | 2.32937504 |
| 62 | Nemaline bodies (HP:0003798) | 2.32513962 |
| 63 | Spastic diplegia (HP:0001264) | 2.31593190 |
| 64 | Short nail (HP:0001799) | 2.31556771 |
| 65 | Myoglobinuria (HP:0002913) | 2.30793241 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.28770555 |
| 67 | Deep venous thrombosis (HP:0002625) | 2.27650276 |
| 68 | Xanthomatosis (HP:0000991) | 2.26521240 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26096330 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.26096330 |
| 71 | Lactic acidosis (HP:0003128) | 2.25488430 |
| 72 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.24344593 |
| 73 | Acute encephalopathy (HP:0006846) | 2.24318400 |
| 74 | Polycythemia (HP:0001901) | 2.22823691 |
| 75 | Mitochondrial inheritance (HP:0001427) | 2.22821996 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 2.22628393 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 2.20794235 |
| 78 | Hyperglycinemia (HP:0002154) | 2.20070694 |
| 79 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.19916298 |
| 80 | Abnormal protein glycosylation (HP:0012346) | 2.19916298 |
| 81 | Abnormal glycosylation (HP:0012345) | 2.19916298 |
| 82 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.19916298 |
| 83 | Ketosis (HP:0001946) | 2.19084742 |
| 84 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.18155591 |
| 85 | Thrombocytosis (HP:0001894) | 2.17916348 |
| 86 | Increased CSF lactate (HP:0002490) | 2.16832413 |
| 87 | Paralysis (HP:0003470) | 2.16502504 |
| 88 | Hypolipoproteinemia (HP:0010981) | 2.15681131 |
| 89 | Muscle fiber inclusion bodies (HP:0100299) | 2.14832131 |
| 90 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14463002 |
| 91 | Muscle stiffness (HP:0003552) | 2.14398778 |
| 92 | Secondary amenorrhea (HP:0000869) | 2.13426948 |
| 93 | Premature ovarian failure (HP:0008209) | 2.12495279 |
| 94 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.10184883 |
| 95 | Hepatocellular carcinoma (HP:0001402) | 2.09694235 |
| 96 | Breast hypoplasia (HP:0003187) | 2.07299430 |
| 97 | Hypergonadotropic hypogonadism (HP:0000815) | 2.06379269 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.05826142 |
| 99 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05390518 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04658568 |
| 101 | Generalized amyotrophy (HP:0003700) | 2.04032701 |
| 102 | Basal cell carcinoma (HP:0002671) | 2.03351179 |
| 103 | Cerebral edema (HP:0002181) | 2.01654333 |
| 104 | Petechiae (HP:0000967) | 2.01273426 |
| 105 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.99842676 |
| 106 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.98361610 |
| 107 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.98361610 |
| 108 | Single umbilical artery (HP:0001195) | 1.98361610 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 1.97259683 |
| 110 | Opisthotonus (HP:0002179) | 1.96050090 |
| 111 | Microretrognathia (HP:0000308) | 1.95591917 |
| 112 | Elbow flexion contracture (HP:0002987) | 1.93685780 |
| 113 | Megaloblastic anemia (HP:0001889) | 1.92838252 |
| 114 | Cerebral hypomyelination (HP:0006808) | 1.92593312 |
| 115 | Reduced antithrombin III activity (HP:0001976) | 1.92431373 |
| 116 | Cholecystitis (HP:0001082) | 1.92338641 |
| 117 | Abnormal gallbladder physiology (HP:0012438) | 1.92338641 |
| 118 | Neck muscle weakness (HP:0000467) | 1.92262754 |
| 119 | Adenoma sebaceum (HP:0009720) | 1.91705027 |
| 120 | Angiofibromas (HP:0010615) | 1.91705027 |
| 121 | Microcytic anemia (HP:0001935) | 1.91591476 |
| 122 | Metabolic acidosis (HP:0001942) | 1.91038781 |
| 123 | Hypertensive crisis (HP:0100735) | 1.88862807 |
| 124 | Ragged-red muscle fibers (HP:0003200) | 1.87065976 |
| 125 | Entropion (HP:0000621) | 1.87039781 |
| 126 | Hypokinesia (HP:0002375) | 1.86888793 |
| 127 | Trismus (HP:0000211) | 1.86125092 |
| 128 | Progressive external ophthalmoplegia (HP:0000590) | 1.85629744 |
| 129 | Ureteral duplication (HP:0000073) | 1.85555676 |
| 130 | Fatigue (HP:0012378) | 1.84995667 |
| 131 | Sparse eyelashes (HP:0000653) | 1.84106730 |
| 132 | Hyperacusis (HP:0010780) | 1.82992697 |
| 133 | Exercise-induced muscle cramps (HP:0003710) | 1.81670738 |
| 134 | Spastic paraparesis (HP:0002313) | 1.81524925 |
| 135 | Abnormality of the gallbladder (HP:0005264) | 1.81157095 |
| 136 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80709153 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 1.80206174 |
| 138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.79351112 |
| 139 | Carpal bone hypoplasia (HP:0001498) | 1.78455026 |
| 140 | Increased serum lactate (HP:0002151) | 1.77877916 |
| 141 | Abnormality of the intrinsic pathway (HP:0010989) | 1.77674554 |
| 142 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77346123 |
| 143 | Osteolytic defects of the hand bones (HP:0009699) | 1.77346123 |
| 144 | Redundant skin (HP:0001582) | 1.77120903 |
| 145 | Gout (HP:0001997) | 1.75941873 |
| 146 | Limb-girdle muscle atrophy (HP:0003797) | 1.75923577 |
| 147 | Ileus (HP:0002595) | 1.75849111 |
| 148 | Lethargy (HP:0001254) | 1.73309998 |
| 149 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.72359875 |
| 150 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.72359875 |
| 151 | Increased hepatocellular lipid droplets (HP:0006565) | 1.71757693 |
| 152 | Rhabdomyosarcoma (HP:0002859) | 1.71182190 |
| 153 | Hepatic necrosis (HP:0002605) | 1.68875863 |
| 154 | Insulin resistance (HP:0000855) | 1.67669980 |
| 155 | Late onset (HP:0003584) | 1.67239497 |
| 156 | Rough bone trabeculation (HP:0100670) | 1.66717943 |
| 157 | Broad distal phalanx of finger (HP:0009836) | 1.66534192 |
| 158 | Degeneration of anterior horn cells (HP:0002398) | 1.65984525 |
| 159 | Abnormality of the anterior horn cell (HP:0006802) | 1.65984525 |
| 160 | Increased connective tissue (HP:0009025) | 1.65196165 |
| 161 | Abnormal platelet function (HP:0011869) | 1.65163170 |
| 162 | Impaired platelet aggregation (HP:0003540) | 1.65163170 |
| 163 | Hypoalphalipoproteinemia (HP:0003233) | 1.65102526 |
| 164 | Pancytopenia (HP:0001876) | 1.62016123 |
| 165 | Abnormality of the common coagulation pathway (HP:0010990) | 1.61986327 |
| 166 | Squamous cell carcinoma (HP:0002860) | 1.59849938 |
| 167 | Ketoacidosis (HP:0001993) | 1.59603025 |
| 168 | Ventricular tachycardia (HP:0004756) | 1.58580561 |
| 169 | Myelodysplasia (HP:0002863) | 1.58415214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.91175461 |
| 2 | EIF2AK1 | 3.14509175 |
| 3 | BCKDK | 3.05828346 |
| 4 | SMG1 | 3.05524490 |
| 5 | IRAK3 | 3.03927452 |
| 6 | CDC7 | 3.02419379 |
| 7 | WEE1 | 2.98282074 |
| 8 | EEF2K | 2.88115755 |
| 9 | BUB1 | 2.86796927 |
| 10 | PKN2 | 2.69868959 |
| 11 | NME2 | 2.64834587 |
| 12 | NEK1 | 2.61154556 |
| 13 | PBK | 2.49215353 |
| 14 | TESK1 | 2.26794107 |
| 15 | TRIB3 | 2.20031972 |
| 16 | NEK2 | 2.13980867 |
| 17 | MAP3K10 | 2.11402626 |
| 18 | FLT3 | 1.96474454 |
| 19 | CDK12 | 1.94162505 |
| 20 | MST1R | 1.90483287 |
| 21 | RPS6KB2 | 1.83842982 |
| 22 | ARAF | 1.81940380 |
| 23 | TTK | 1.72485052 |
| 24 | STK10 | 1.72112276 |
| 25 | ERN1 | 1.68764261 |
| 26 | MAP4K1 | 1.63849473 |
| 27 | CDK4 | 1.56575430 |
| 28 | MAP3K8 | 1.52391838 |
| 29 | MAP2K3 | 1.52358586 |
| 30 | STK4 | 1.46455635 |
| 31 | CDK7 | 1.46277245 |
| 32 | TSSK6 | 1.44420066 |
| 33 | MAP3K11 | 1.43700954 |
| 34 | SCYL2 | 1.43661755 |
| 35 | BRSK2 | 1.39751053 |
| 36 | TTN | 1.32294960 |
| 37 | AURKB | 1.32253934 |
| 38 | PRPF4B | 1.30018155 |
| 39 | KDR | 1.29573055 |
| 40 | TLK1 | 1.26273577 |
| 41 | DYRK3 | 1.25920310 |
| 42 | PLK1 | 1.25884520 |
| 43 | LRRK2 | 1.24316357 |
| 44 | MAPKAPK3 | 1.22002707 |
| 45 | RPS6KA4 | 1.21005303 |
| 46 | ATR | 1.14977969 |
| 47 | PIM1 | 1.12705590 |
| 48 | CDK8 | 1.12699294 |
| 49 | ACVR1B | 1.12672040 |
| 50 | TESK2 | 1.10902137 |
| 51 | EIF2AK3 | 1.10021755 |
| 52 | LIMK1 | 1.07924572 |
| 53 | PIM2 | 1.04473192 |
| 54 | GRK6 | 1.04368326 |
| 55 | DAPK1 | 1.03639441 |
| 56 | VRK1 | 1.03431470 |
| 57 | MAPK11 | 1.02857111 |
| 58 | PAK4 | 1.00218391 |
| 59 | PDK2 | 0.99236997 |
| 60 | SRPK1 | 0.98921724 |
| 61 | BRSK1 | 0.98290380 |
| 62 | TAOK2 | 0.95659063 |
| 63 | AURKA | 0.94314875 |
| 64 | TGFBR1 | 0.94156109 |
| 65 | EPHA2 | 0.93061937 |
| 66 | PASK | 0.93014013 |
| 67 | CHEK1 | 0.91662377 |
| 68 | CHEK2 | 0.84062997 |
| 69 | ZAK | 0.83376708 |
| 70 | TAF1 | 0.82031925 |
| 71 | STK16 | 0.81349094 |
| 72 | SIK1 | 0.79951275 |
| 73 | BRAF | 0.79406297 |
| 74 | CDK6 | 0.78789634 |
| 75 | MTOR | 0.77644845 |
| 76 | ZAP70 | 0.73995927 |
| 77 | LMTK2 | 0.73003725 |
| 78 | MAP3K3 | 0.68454445 |
| 79 | CCNB1 | 0.68237023 |
| 80 | PDK3 | 0.66659685 |
| 81 | PDK4 | 0.66659685 |
| 82 | RAF1 | 0.65471576 |
| 83 | AKT2 | 0.65427850 |
| 84 | TYK2 | 0.63366435 |
| 85 | CDK2 | 0.61642157 |
| 86 | ATM | 0.60986193 |
| 87 | BRD4 | 0.60953212 |
| 88 | ALK | 0.60651684 |
| 89 | PLK4 | 0.59618440 |
| 90 | CSNK2A2 | 0.58364252 |
| 91 | BTK | 0.57218662 |
| 92 | JAK3 | 0.57155983 |
| 93 | IRAK2 | 0.53548047 |
| 94 | TAOK1 | 0.52579453 |
| 95 | ERBB4 | 0.51980178 |
| 96 | PTK6 | 0.51544346 |
| 97 | MET | 0.50888182 |
| 98 | CSNK2A1 | 0.48195309 |
| 99 | STK3 | 0.47086588 |
| 100 | DAPK3 | 0.46745293 |
| 101 | PTK2 | 0.46369951 |
| 102 | ILK | 0.45949909 |
| 103 | NME1 | 0.45749805 |
| 104 | FGFR4 | 0.44709090 |
| 105 | PAK2 | 0.44384390 |
| 106 | ICK | 0.43838521 |
| 107 | PAK1 | 0.43709094 |
| 108 | EIF2AK2 | 0.43460632 |
| 109 | CDK9 | 0.42030805 |
| 110 | RPS6KA5 | 0.42003755 |
| 111 | CSF1R | 0.41422112 |
| 112 | ABL2 | 0.41003179 |
| 113 | MOS | 0.39870235 |
| 114 | OBSCN | 0.38324900 |
| 115 | CLK1 | 0.37228071 |
| 116 | CDK1 | 0.36711078 |
| 117 | PLK3 | 0.36273728 |
| 118 | BMX | 0.36171217 |
| 119 | RPS6KA1 | 0.35511818 |
| 120 | CSNK1G3 | 0.35418859 |
| 121 | MAP2K2 | 0.35355826 |
| 122 | MAP3K7 | 0.34875026 |
| 123 | JAK2 | 0.34646093 |
| 124 | TBK1 | 0.32651028 |
| 125 | PRKCI | 0.32117663 |
| 126 | RPS6KC1 | 0.30646384 |
| 127 | RPS6KL1 | 0.30646384 |
| 128 | RPS6KA6 | 0.30241794 |
| 129 | MAP3K1 | 0.28467088 |
| 130 | CAMK2G | 0.24513049 |
| 131 | MAPKAPK2 | 0.24156062 |
| 132 | MST4 | 0.23922934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.80934969 |
| 2 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.07127354 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.92331290 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.51940944 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.31885017 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.30753166 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.20755897 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.10746548 |
| 9 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.10456537 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07077033 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.99058742 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93428524 |
| 13 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.92630585 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.92015573 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 1.90209945 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86666607 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86540466 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.86104649 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76132042 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.75393988 |
| 21 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.72010670 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66375017 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.63496778 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.62346926 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60792803 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.56900892 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55652984 |
| 28 | Cell cycle_Homo sapiens_hsa04110 | 1.54521640 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52899436 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50374558 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.49851890 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46797679 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46045092 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44835306 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.36650587 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35143902 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27990450 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26659120 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.24407173 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.23997721 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23058297 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21616171 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.16009367 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.14716318 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14653341 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03916231 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99982574 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 0.97325558 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95089860 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94445639 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93063567 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92952709 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92883599 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92466152 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92138419 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91289125 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88383546 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.87126295 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86782791 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86576320 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85625808 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.85455382 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85044388 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81487747 |
| 65 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.80063983 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79505536 |
| 67 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75446819 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74779749 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74387206 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70514518 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67452055 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66718293 |
| 73 | Purine metabolism_Homo sapiens_hsa00230 | 0.64634561 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64107175 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63893762 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63593772 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62774352 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60789181 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56730768 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.56327068 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55400237 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53629620 |
| 83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53228207 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51500806 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.51482123 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51342001 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50449440 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50083349 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46704034 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46408184 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45556408 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44911457 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42958830 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42432667 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42129696 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40944747 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39564783 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.39352595 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39246707 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38159343 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37752109 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37696735 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37534279 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36896429 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.35577762 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34293439 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33768943 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33373337 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33138420 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31537042 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29256852 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27927321 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.27843142 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27596915 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27017937 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23370877 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.23305978 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.21251029 |
| 119 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.20971953 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.17146508 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16544623 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.15488352 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.11724493 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.11163890 |

